格隆汇8月12日丨润达医疗(603108.SH)在互动平台表示，公司暂不涉及脑机接口相关技术。 ...

A股继续大涨 8月12日，A股震荡走强，沪指录得7连阳，再度刷新年内新高。截至收盘， 沪指涨0.5%，深成指涨0.53%，创业板指涨1.24%。 | 代码 | 名称 | | 涨幅% | 现价 | 涨跌 | | --- | --- | --- | --- | --- | --- | | 688584 | 一海合品 | K | 20.00 | 22.86 | 3.81 | | 288526 | 寒武纪-U | K | 20.00 | 848.88 | 141.48 | | 688702 | 盛科通信-U | K | 19.27 | 78.00 | 12.60 | | 300398 | 飞凯材料 | R | 11.81 | 23.19 | 2.45 | | 688498 | 源杰科技 | ાર | 10.71 | 270.03 | 26.13 | | 688621 | 元原股份 | ાર | 9.24 | 107.93 | a.13 | | 300671 | 富洒微 | R | 9.10 | 42.78 | 3.57 | | 688362 | 角矽电子 | ાર | 8.79 | 35.90 | 2.90 | | ...

截至8月12日收盘，脑机接口概念上涨2.37%，位居概念板块涨幅第1，板块内，27股上涨，麒盛科技、 创新医疗等涨停，麦澜德、翔宇医疗、诚益通等涨幅居前，分别上涨18.06%、11.02%、6.87%。跌幅居 前的有际华集团、海格通信、荣泰健康等，分别下跌7.37%、2.90%、2.86%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 脑机接口 | 2.37 | PEEK材料 | -1.58 | | 光刻机 | 2.26 | 稀土永磁 | -1.53 | | 中国AI 50 | 2.01 | MLOps概念 | -1.39 | | 国家大基金持股 | 1.83 | 动物疫苗 | -1.34 | | 光刻胶 | 1.68 | 重组蛋白 | -1.14 | | 深圳国企改革 | 1.56 | 转基因 | -1.12 | | 牙科医疗 | 1.51 | DRG/DIP | -1.12 | | 液冷服务器 | 1.46 | 细胞免疫治疗 | -1.10 | | 光纤概念 | 1.43 | 培育钻石 | -1.04 ...

Market Overview - The recombinant protein sector experienced a decline of 1.14%, ranking among the top losers in the concept sector as of the market close on August 12 [1] - Notable stocks within this sector that saw significant declines include HaiTe Bio, Kexing Pharmaceutical, and Huiyu Pharmaceutical, while 13 stocks recorded gains, with *ST WanFang, Zhenghai Bio, and Huabei Pharmaceutical leading the increases at 3.42%, 2.66%, and 2.08% respectively [1] Capital Flow - The recombinant protein sector faced a net outflow of 484 million yuan from major funds, with 32 stocks experiencing net outflows, and 8 stocks seeing outflows exceeding 30 million yuan [1] - HaiTe Bio led the outflows with a net withdrawal of 79.69 million yuan, followed by YiPinHong, Chengdu XianDao, and BeiDa Pharmaceutical with outflows of 72.64 million yuan, 64.49 million yuan, and 52.64 million yuan respectively [1] Top Gainers and Losers - The top gainers in the recombinant protein sector included DeZhan Health, HuaXi Bio, and BoRui Pharmaceutical, with net inflows of 68.21 million yuan, 24.69 million yuan, and 17.58 million yuan respectively [3] - The detailed outflow list highlights stocks such as HaiTe Bio (-8.67%), YiPinHong (-2.70%), and Chengdu XianDao (-2.88%) as the most affected by capital withdrawal [2]

格隆汇8月12日丨迦南科技(300412.SZ)在互动平台表示，公司暂未涉及"脑机接口、脑科医疗"等相关业 务，公司会持续关注相关技术的发展及应用。 ...

Market Overview - The Hong Kong stock market showed mixed results with the Hang Seng Technology Index rising by 0.25%, briefly surpassing the 25,000-point mark, while the Hang Seng Index increased by 0.32% and the Hang Seng Technology Index fell by 0.38% [1] Sector Performance - Large technology stocks exhibited divergent trends, with Xiaomi up by 1.77%, NetEase rising by 1%, and JD.com and Meituan also in the green, while Kuaishou plummeted over 9%, Alibaba dropped by 1.6%, and Baidu fell by 1.34% [1] - The semiconductor sector was boosted by rumors, leading to a surge in shares of Cambricon Technology, which hit the 20% daily limit, driving up Hong Kong semiconductor stocks collectively, with Hongguang Semiconductor rising by 11.5% and SMIC and Hua Hong Semiconductor increasing by over 5% [1] - Insurance stocks performed well as a result of a scheduled interest rate cut and an increase in the proportion of dividend insurance, with China Pacific Insurance leading the gains, rising over 6% [1] - Other active sectors included coal, dairy products, Apple concept stocks, Chinese brokerage firms, domestic property stocks, oil, brain-computer interface concepts, and shipping stocks [1] Declining Sectors - The rare earth concept stocks and paper industry stocks experienced significant declines, while the biopharmaceutical sector showed a high open but low close, with BGI Genomics and Livzon Pharmaceutical leading the losses among innovative drug stocks [1] - Logistics, vocational education, and military industry stocks also saw declines [1]

Market Overview - On August 12, the market experienced a steady rise, with the Shanghai Composite Index recording a seven-day winning streak and all three major indices reaching new highs for the year. The A-share market had a total trading volume of 1.91 trillion yuan, an increase of 554.26 billion yuan compared to the previous trading day. The Shanghai Composite Index rose by 0.5%, the Shenzhen Component Index by 0.53%, and the ChiNext Index by 1.24% [1]. Sector Performance - Chip stocks surged in the afternoon, with Cambrian Technology hitting the daily limit and reaching a historical high. AI hardware stocks also showed strength, with several stocks, including Shenghong Technology, setting new historical highs. Local stocks from Xinjiang maintained strong performance, with companies like Xinjiang Communications Construction achieving three consecutive gains. Conversely, military stocks underwent adjustments, with companies like Jieqiang Equipment dropping over 5%. The semiconductor, port, CPO, and Xinjiang sectors led the gains, while PEEK materials, rare earth permanent magnets, military, and lithium mining sectors saw declines [5]. Cambrian Technology Insights - Cambrian Technology's stock price reached 848.88 yuan per share, marking a historical high with a market capitalization of approximately 335.13 billion yuan. The company adjusted its fundraising plan, reducing the total amount from no more than 4.98 billion yuan to no more than 3.99 billion yuan. Analysts believe this reduction in fundraising will decrease equity dilution and enhance the probability of successful completion. The company is expected to improve its competitiveness with new product directions, and the AI chip industry is anticipated to see a significant increase in market potential [7][8]. AI Technology Developments - Huawei officially launched its AI inference innovation technology, UCM, which focuses on KV Cache management to enhance inference acceleration. This technology has been applied in various business scenarios, achieving positive results. The brain-computer interface concept is gaining traction, with companies like Mylande and Xiangyu Medical seeing significant stock price increases. The Ministry of Industry and Information Technology has issued guidelines to promote the brain-computer interface industry, aiming for breakthroughs in key technologies by 2027 and establishing a competitive industry ecosystem by 2030 [9][10]. Financing Trends - As of August 11, the A-share market's financing balance reached 2.0122 trillion yuan, the highest since July 2, 2015. This year, the financing balance has increased by 158.06 billion yuan, with the pharmaceutical and biotechnology sectors seeing significant inflows. The net buying amount for BYD was the highest, while Dongfang Wealth saw the largest net selling. The current financing balance relative to the market's free float market value remains low compared to 2015, indicating potential for market sentiment improvement with increased policy support [12].

Market Overview - A-shares experienced a strong opening and closing, with all three major indices reaching new highs for the year. The Shanghai Composite Index rose by 0.50% to 3665 points, the Shenzhen Component increased by 0.53%, and the ChiNext Index surged by 1.24% [1][2] - The total trading volume for the day was 1.91 trillion yuan, an increase of 553 billion yuan compared to the previous trading day, with over 3100 stocks declining [1] Sector Performance - The brain-computer interface sector led the gains, with stocks like Mailland and Xiangyu Medical hitting the daily limit, while the multi-financial sector also saw significant increases, with Jiuding Investment reaching the daily limit [2][4] - Semiconductor and AI chip sectors experienced a midday surge, with Cambrian Technology hitting a 20% limit up [2][4] - The gas sector showed strong performance, with stocks like Dongfang Huanyu and Xinjiang Huojun reaching the daily limit [2][8] - The real estate sector saw widespread gains, with stocks such as Shahe Co. and Electronic City hitting the daily limit [2][11] Notable Stocks - In the brain-computer interface sector, Mailland rose by 18.06% to 52.83 yuan, while Xiangyu Medical increased by 11.02% to 64.40 yuan [5] - In the semiconductor sector, Shanghai Hejing and Cambrian Technology both hit the daily limit, with Cambrian Technology priced at 848.88 yuan, up 20% [9] - Jiuding Investment in the multi-financial sector rose by 10.01% to 19.67 yuan [7] - The gas sector saw Dongfang Huanyu and Xinjiang Huojun both increase by 10% [8] Market Outlook - Citic Securities indicated that the A-share market may face some resistance in the short term due to weaker-than-expected PPI and the expiration of tariff agreements, but it remains in a bull market continuation phase. The recent industry rotation suggests opportunities in new low-segment varieties, particularly in defense, AI computing, semiconductors, and innovative pharmaceuticals [1][2][15]

Group 1 - The company has established a dual-track strategy focusing on both "invasive and non-invasive" approaches in the brain-computer interface (BCI) sector [1] - In the non-invasive serious medical field, the company is integrating existing rehabilitation equipment with brain-computer interfaces to enhance product functionality and is actively promoting commercialization [1] - Beyond the medical field, the company is exploring applications in "non-medical" scenarios, including education, elderly care, and health, having launched a BCI biofeedback system aimed at attention detection and training in the education sector [1] Group 2 - In the invasive field, the company is constructing a BCI technology research verification center and an animal testing center, which are crucial for its strategic layout in the BCI domain [1] - These two centers will create a complete innovation chain from "basic research - technology verification - achievement transformation" [1]

Core Insights - The brain-computer interface (BCI) industry is entering a phase of application popularization driven by technological advancements and policy support [1][2][3] Technological Progress - Significant advancements in underlying technologies such as microelectronics, materials science, chips, neuroscience, and algorithms have laid the foundation for breakthroughs in BCI [1] Policy Support - The National Healthcare Security Administration (NHSA) has initiated pricing projects for BCI technologies, paving the way for clinical application and reimbursement starting July 2025 [2] - In January 2025, Beijing and Shanghai released action plans for BCI development, followed by a detailed implementation opinion from multiple government departments in August 2025 [3] Global Development Trends - Neuralink has sparked a global surge in BCI research, with the first surgery completed in January 2024 and seven patients implanted by June 2025 [4] - Other companies like Apple and Synchron are also advancing BCI technologies, with Apple demonstrating thought-controlled iPad technology for ALS patients [4] Domestic Industry Progress - Domestic companies are rapidly advancing BCI research, with significant milestones achieved in clinical trials, including the first clinical implant by Tsinghua University and Xuanwu Hospital in October 2023 [5] - The first complete paraplegic patient regaining the ability to stand and walk was reported in March 2025, showcasing the potential for commercial applications [5]